Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | YWHAZ | P63104 | 3/20 | 0.37 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
| ▸ | TLR2 | O60603 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28276205 | 0.90 | MAPK1 (0.38) | YWHAZTLR2 | |
| SCHEMBL28276199 | 0.90 | MAPK1 (0.38) | YWHAZTLR2 | |
| SCHEMBL28274791 | 0.90 | MAPK1 (0.38) | YWHAZTLR2 | |
| SCHEMBL28274780 | 0.90 | MAPK1 (0.38) | YWHAZTLR2 | |
| SCHEMBL16882238 | 0.87 | YWHAZ (0.37) | YWHAZCA1CA2CA9MEN1 | |
| SCHEMBL14330425 | 0.86 | YWHAZ (0.36) | YWHAZCA1CA2CA9 | |
| SCHEMBL13909435 | 0.81 | YWHAZ (0.36) | YWHAZCA1CA2CA9 | |
| SCHEMBL4205268 | 0.81 | YWHAZ (0.36) | YWHAZCA1CA2CA9 | |
| SCHEMBL10889700 | 0.81 | MEN1 (0.45) | YWHAZCA1CA2CA9MEN1 | |
| SCHEMBL7155153 | 0.81 | MEN1 (0.45) | YWHAZCA1CA2CA9MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105585597-B | The preparation method of glucosan derivative cationic-liposome nano particle | 湖南师范大学 | 2019-02-19 | — | — | CN | claimed |
| CN-105585597-B | The preparation method of glucosan derivative cationic-liposome nano particle | 湖南师范大学 | 2019-02-19 | — | — | CN | disclosed |